The leading trade group representing the brand-name pharmaceutical industry late Thursday urged a federal judge to toss out the Medicare agency’s drug price negotiation program.
The Pharmaceutical Research and Manufacturers of America filed the request for summary judgment in the US District Court for the Western District of Texas.
The group, along with the National Infusion Center Association and the Global Colon Cancer Association, said they want a judge to issue a decision on their three claims against the drug price negotiation program put in place by the Inflation Reduction Act. They say the program violates the separation of powers ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.